| For: | Simbrunner B, Mandorfer M, Trauner M, Reiberger T. Gut-liver axis signaling in portal hypertension. World J Gastroenterol 2019; 25(39): 5897-5917 [PMID: 31660028 DOI: 10.3748/wjg.v25.i39.5897] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i39/5897.htm |
| Number | Citing Articles |
| 1 |
Lukas Hartl, Mathias Jachs, Christopher Desbalmes, Dunja Schaufler, Benedikt Simbrunner, Rafael Paternostro, Philipp Schwabl, David Josef Maria Bauer, Georg Semmler, Bernhard Scheiner, Theresa Bucsics, Ernst Eigenbauer, Rodrig Marculescu, Thomas Szekeres, Markus Peck-Radosavljevic, Stefan Kastl, Michael Trauner, Mattias Mandorfer, Thomas Reiberger. The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes. Hepatology International 2021; 15(5) doi: 10.1007/s12072-021-10203-9
|
| 2 |
Igor G. Bakulin, Inna A. Oganezova, Maria I. Skalinskaya, Ekaterina V. Skazyvaeva. Liver cirrosis and complication risk management. Terapevticheskii arkhiv 2021; 93(8) doi: 10.26442/00403660.2021.08.200917
|
| 3 |
Xuyu Xiang, Jiang Zhu, Jie Jiang, Peng Ding, Yi Zhu, Ke Cheng, Yingzi Ming. Unique gut microbiota and metabolomic profiling as biomarker of post-transplant recovery in acute-on-chronic liver failure after liver transplantation. Applied Microbiology and Biotechnology 2026; 110(1) doi: 10.1007/s00253-026-13774-5
|
| 4 |
Lorenz Balcar, Georg Semmler, Katharina Pomej, Benedikt Simbrunner, David Bauer, Lukas Hartl, Mathias Jachs, Rafael Paternostro, Theresa Bucsics, Matthias Pinter, Michael Trauner, Mattias Mandorfer, Thomas Reiberger, Bernhard Scheiner. Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute‐on‐chronic liver failure. United European Gastroenterology Journal 2021; 9(4) doi: 10.1002/ueg2.12089
|
| 5 |
Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Elena Poluektova, Anna Kudryavtseva, George Krasnov. Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis. World Journal of Gastroenterology 2022; 28(10): 1067-1077 doi: 10.3748/wjg.v28.i10.1067
|
| 6 |
Benedikt Simbrunner, Lukas Hartl, Mathias Jachs, David J.M. Bauer, Bernhard Scheiner, Benedikt Silvester Hofer, Albert Friedrich Stättermayer, Rodrig Marculescu, Michael Trauner, Mattias Mandorfer, Thomas Reiberger. Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosis. JHEP Reports 2023; 5(5) doi: 10.1016/j.jhepr.2023.100712
|
| 7 |
Yangjie Li, Lingna Lyu, Huiguo Ding. The potential roles of gut microbiome in porto-sinusoidal vascular disease: an under-researched crossroad. Frontiers in Microbiology 2025; 16 doi: 10.3389/fmicb.2025.1556667
|
| 8 |
Yali Xu, Jianfeng Duan, Dacheng Wang, Jiali Liu, Xiancheng Chen, Xian-Yang Qin, Wenkui Yu. Akkermansia muciniphila Alleviates Persistent Inflammation, Immunosuppression, and Catabolism Syndrome in Mice. Metabolites 2023; 13(2) doi: 10.3390/metabo13020194
|
| 9 |
Dalila Costa, Benedikt Simbrunner, Mathias Jachs, Lukas Hartl, David Bauer, Rafael Paternostro, Philipp Schwabl, Bernhard Scheiner, Albert Friedrich Stättermayer, Matthias Pinter, Michael Trauner, Mattias Mandorfer, Thomas Reiberger. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality. Journal of Hepatology 2021; 74(4) doi: 10.1016/j.jhep.2020.10.004
|
| 10 |
Asmaa.F. Khafaga, Hassan A. Rudayni, Nourhan E. Khalifa, Abdullah S. Alawam, Ahmed A. Allam, Ayman E. Taha, Mohammed A.E. Naiel, Mohamed E. Abd El-Hack. The gut–liver axis in chronic liver diseases: An integrative immunopathological perspective bridging animal models and human evidence. Tissue and Cell 2026; 101 doi: 10.1016/j.tice.2026.103456
|
| 11 |
Miguel Suárez, Raquel Martínez, Raquel Gómez-Molina, Jorge Mateo. Infection risk and management in patients with cirrhosis: A critical overview. World Journal of Hepatology 2025; 17(5): 104468 doi: 10.4254/wjh.v17.i5.104468
|
| 12 |
Claudia D. Fuchs, Benedikt Simbrunner, Maximillian Baumgartner, Clarissa Campbell, Thomas Reiberger, Michael Trauner. Bile acid metabolism and signalling in liver disease. Journal of Hepatology 2025; 82(1) doi: 10.1016/j.jhep.2024.09.032
|
| 13 |
Mattias Mandorfer, Annalisa Berzigotti. Portal Hypertension VII. 2022; doi: 10.1007/978-3-031-08552-9_4
|
| 14 |
Elena Shirokova, Elena Poluektova, Irina Efremova, Vladimir Ivashkin, Roman Maslennikov. Probiotics in hepatology: An update. World Journal of Hepatology 2021; 13(9): 1154-1166 doi: 10.4254/wjh.v13.i9.1154
|
| 15 |
Hiroki Nishikawa, Hirayuki Enomoto, Shuhei Nishiguchi, Hiroko Iijima. Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis. International Journal of Molecular Sciences 2020; 21(15) doi: 10.3390/ijms21155254
|
| 16 |
Haonan Zhang, Jian Gao, George Vousden. Antibiotics and probiotics on hepatic venous pressure gradient in cirrhosis: A systematic review and a meta-analysis. PLOS ONE 2022; 17(8) doi: 10.1371/journal.pone.0273231
|
| 17 |
Shoumi Haldar, Nounenuo Yhome, Yuvashree Muralidaran, Senthilkumar Rajagopal, Prabhakar Mishra. Nanoplastics Toxicity Specific to Liver in Inducing Metabolic Dysfunction—A Comprehensive Review. Genes 2023; 14(3) doi: 10.3390/genes14030590
|
| 18 |
Xiaomei Wang, Kaili Deng, Pei Zhang, Qiqing Chen, Jason T. Magnuson, Wenhui Qiu, Yuping Zhou. Microplastic-mediated new mechanism of liver damage: From the perspective of the gut-liver axis. Science of The Total Environment 2024; 919 doi: 10.1016/j.scitotenv.2024.170962
|
| 19 |
Gang Chang, Jie Sun, Jianhua Li, Tao Li. Effect of Probiotics on Portal Hypertension (PH) with Cirrhosis: A Systematic Review and Meta-Analysis. Clinics and Research in Hepatology and Gastroenterology 2024; 48(6) doi: 10.1016/j.clinre.2024.102361
|
| 20 |
Honglei Zhang, Yun Lu, Yuanlei Zhang, Jiayu Dong, Su Jiang, Yunping Tang. DHA-enriched phosphatidylserine ameliorates cyclophosphamide-induced liver injury via regulating the gut-liver axis. International Immunopharmacology 2024; 140 doi: 10.1016/j.intimp.2024.112895
|
| 21 |
Shihao Zheng, Fan-e Cheng, Xiaoke Li, Hongbo Du, Peng Zhang, Xiaobin Zao, Yongan Ye, Xinyue Shi. Gut microbiota dysbiosis in chronic liver disease: Mechanisms driving hepatocellular carcinoma progression and therapeutic implications of Chinese medicine. Molecular Aspects of Medicine 2026; 110 doi: 10.1016/j.mam.2026.101490
|
| 22 |
|
| 23 |
Rachel M. Golonka, Johnathan Kawika Cooper, Rochell Issa, Pratyush Pavan Devarasetty, Veda Gokula, Joshua Busken, Jasenka Zubcevic, Jennifer Hill, Matam Vijay-Kumar, Bindu Menon, Bina Joe. Impact of Nutritional Epigenetics in Essential Hypertension: Targeting microRNAs in the Gut-Liver Axis. Current Hypertension Reports 2021; 23(5) doi: 10.1007/s11906-021-01142-9
|
| 24 |
Saleh Y Alabbas, Rabina Giri, Iulia Oancea, Julie Davies, Veronika Schreibner, Timothy H Florin, Jakob Begun. Gut inflammation and adaptive immunity amplify acetaminophen toxicity in bowel and liver. Journal of Gastroenterology and Hepatology 2023; 38(4) doi: 10.1111/jgh.16102
|
| 25 |
Søren Møller, Nina Kimer, Mads Barløse, Flemming Bendtsen. Pathophysiological-based treatments of complications of cirrhosis. Scandinavian Journal of Gastroenterology 2020; 55(4) doi: 10.1080/00365521.2020.1744709
|
| 26 |
Antonietta Gerarda Gravina, Mario Romeo, Raffaele Pellegrino, Concetta Tuccillo, Alessandro Federico, Carmelina Loguercio. Just Drink a Glass of Water? Effects of Bicarbonate–Sulfate–Calcium–Magnesium Water on the Gut–Liver Axis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.869446
|
| 27 |
David Swilling, Ashini Patel, Arun B. Jesudian, Martin Laville, Ryan Hickey, Bedros Taslakian, Akhilesh K. Sista. Impact of Transjugular Intrahepatic Shunt Creation on the Gut Microbiota. Journal of Vascular and Interventional Radiology 2024; 35(3) doi: 10.1016/j.jvir.2023.12.003
|
| 28 |
Tim Vanuytsel, Jan Tack, Ricard Farre. The Role of Intestinal Permeability in Gastrointestinal Disorders and Current Methods of Evaluation. Frontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.717925
|
| 29 |
Lukas Hartl, Benedikt Simbrunner, Mathias Jachs, Peter Wolf, David Josef Maria Bauer, Bernhard Scheiner, Lorenz Balcar, Georg Semmler, Michael Schwarz, Rodrig Marculescu, Michael Trauner, Mattias Mandorfer, Thomas Reiberger. An impaired pituitary–adrenal signalling axis in stable cirrhosis is linked to worse prognosis. JHEP Reports 2023; 5(8) doi: 10.1016/j.jhepr.2023.100789
|
| 30 |
Shujie Xu, Qi Wang, Fei Wang, Xiang Li, Baikui Wang, Yuanhao Zhou, Peng Zou, Li Tang, Dongyou Yu, Weifen Li. Improved immune function of Chinese soft-shelled turtles (Pelodiscus sinensis) through oral probiotics via the TLR signaling pathway. Aquaculture 2022; 555 doi: 10.1016/j.aquaculture.2022.738126
|
| 31 |
Alix Bruneau, Jana Hundertmark, Adrien Guillot, Frank Tacke. Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.725390
|
| 32 |
Jeanne A. Ishimwe, Thanvi Dola, Lale A. Ertuglu, Annet Kirabo. Bile acids and salt-sensitive hypertension: a role of the gut-liver axis. American Journal of Physiology-Heart and Circulatory Physiology 2022; 322(4) doi: 10.1152/ajpheart.00027.2022
|
| 33 |
Li Wang, Zheng-Min Cao, Li-Li Zhang, Juan-mei Li, Wen-liang Lv. The Role of Gut Microbiota in Some Liver Diseases: From an Immunological Perspective. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.923599
|
| 34 |
Hiroyuki Masuda, Tadashi Namisaki, Kosuke Kaji, Norihisa Nishimura, Hiroaki Takaya, Takashi Inoue, Akihiko Shibamoto, Satoshi Iwai, Masayoshi Takami, Yuki Tsuji, Yukihisa Fujinaga, Shinya Sato, Koh Kitagawa, Akira Mitoro, Kiyoshi Asada, Hitoshi Yoshiji. Lipopolysaccharide Binding Protein and Soluble Mannose Receptor as Biomarkers for Acute Kidney Injury in Cirrhosis. Hepatology Research 2026; doi: 10.1111/hepr.70217
|
| 35 |
Natalia Andújar-Tenorio, Isabel Prieto, Antonio Cobo, Ana M. Martínez-Rodríguez, Marina Hidalgo, Ana Belén Segarra, Manuel Ramírez, Antonio Gálvez, Magdalena Martínez-Cañamero, Branislav T. Šiler. High fat diets induce early changes in gut microbiota that may serve as markers of ulterior altered physiological and biochemical parameters related to metabolic syndrome. Effect of virgin olive oil in comparison to butter. PLOS ONE 2022; 17(8) doi: 10.1371/journal.pone.0271634
|
| 36 |
Mathias Jachs, Lukas Hartl, Dunja Schaufler, Christopher Desbalmes, Benedikt Simbrunner, Ernst Eigenbauer, David Josef Maria Bauer, Rafael Paternostro, Philipp Schwabl, Bernhard Scheiner, Theresa Bucsics, Albert Friedrich Stättermayer, Matthias Pinter, Michael Trauner, Mattias Mandorfer, Thomas Reiberger. Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes. Gut 2021; 70(9) doi: 10.1136/gutjnl-2020-322712
|
| 37 |
Radmila V Karpova, Ksenia S Russkova, Yuliya N Lavrentieva. <p>Increases in Autoantibody Level Associated with Degenerative Changes in the Intestinal Mucosa in Liver Cirrhosis</p>. Clinical and Experimental Gastroenterology 2020; doi: 10.2147/CEG.S263176
|
| 38 |
Xiaotong Xu, Tong Zhu, Changyou Jing, Minjie Jiang, Yunlai Fu, Fang Xie, Qinghua Meng, Jianjun Li. Hepatic encephalopathy treatment after transjugular intrahepatic portosystemic shunt: a new perspective on the gut microbiota. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1423780
|
| 39 |
Qian Zhang, Guangming Xiang, Hongyue Li, Shirui Peng, Liming Wang, Ting Wu, Jian Du. Bacterial Infections in Cirrhosis: New Insights from Pathophysiology to Clinical Management. Textile & Leather Review 2026; 9 doi: 10.31881/TLR.2026.4528
|
| 40 |
Irina Efremova, Roman Maslennikov, Elena Poluektova, Oleg Medvedev, Anna Kudryavtseva, George Krasnov, Maria Fedorova, Filipp Romanikhin, Maria Zharkova, Oxana Zolnikova, Gyunay Bagieva, Vladimir Ivashkin. Presepsin as a biomarker of bacterial translocation and an indicator for the prescription of probiotics in cirrhosis. World Journal of Hepatology 2024; 16(5): 822-831 doi: 10.4254/wjh.v16.i5.822
Abstract(679) |
Core Tip(689) |
Full Article(HTML)(1895)
|
Full Article (PDF)-857K(195)
|
Full Article with Cover (PDF)-3851K(212)
|
Full Article (XML)-134K(136)
|
Audio-711K(124)
|
Peer-Review Report-226K(151)
|
Answering Reviewers-34K(129)
|
Supplementary Material-129K(136)
|
Times Cited (4)
|
Total Visits (3461)
|
Open
|
| 41 |
Mathias Declercq, Lucas Treps, Vincent Geldhof, Nadine V. Conchinha, Laura P. M. H. de Rooij, Abhishek Subramanian, Magalie Feyeux, Marine Cotinat, Bram Boeckx, Stefan Vinckier, Lieven Dupont, Francois Vermeulen, Mieke Boon, Marijke Proesmans, Louis Libbrecht, Jacques Pirenne, Diethard Monbaliu, Ina Jochmans, Mieke Dewerchin, Guy Eelen, Tania Roskams, Stijn Verleden, Diether Lambrechts, Peter Carmeliet, Peter Witters. Single‐cell RNA sequencing of cystic fibrosis liver disease explants reveals endothelial complement activation. Liver International 2024; 44(9) doi: 10.1111/liv.15963
|
| 42 |
Georg Semmler, Mattias Mandorfer. Nachbetreuung von PatientInnen mit „sustained virologic response“. Journal für Gastroenterologische und Hepatologische Erkrankungen 2020; 18(4) doi: 10.1007/s41971-020-00087-1
|
| 43 |
Guole Nie, Honglong Zhang, Danna Xie, Jun Yan, Xun Li. Liver cirrhosis and complications from the perspective of dysbiosis. Frontiers in Medicine 2024; 10 doi: 10.3389/fmed.2023.1320015
|
| 44 |
Y. Linda Wu, Grace van Hyfte, Umut Özbek, Marlene Reincke, Anuhya Gampa, Yehia I. Mohamed, Naoshi Nishida, Brooke Wietharn, Suneetha Amara, Pei-Chang Lee, Bernhard Scheiner, Lorenz Balcar, Matthias Pinter, Arndt Vogel, Arndt Weinmann, Anwaar Saeed, Anjana Pillai, Lorenza Rimassa, Abdul Rafeh Naqash, Mahvish Muzaffar, Yi-Hsiang Huang, Ahmed O. Kaseb, Masatoshi Kudo, David J. Pinato, Celina Ang. Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1128569
|
| 45 |
Pietro Di Fazio, Sophia Mielke, Isabell T Böhm, Malte Buchholz, Sami Matrood, Detlef Schuppan, Thaddeus Wissniowski. Toll-like receptor 5 tunes hepatic and pancreatic stellate cells activation. BMJ Open Gastroenterology 2023; 10(1) doi: 10.1136/bmjgast-2023-001148
|
| 46 |
Nikolaus Pfisterer, Irina Lie‐Ungurean, Jurij Maurer, David Bauer, Hannah Hengstschlaeger, Alexander Noe, Lorenz Balcar, Bernhard Scheiner, Philipp Schwabl, Rodrig Marculescu, Katharina Wöran, Behrang Mozayani, Christian Madl, Michael Trauner, Mattias Mandorfer, Thomas Reiberger, Benedikt Simbrunner. The Link of Portal‐Hypertensive Gastropathy to Anaemia, Systemic Inflammation and Disease Progression in Cirrhosis. Liver International 2026; 46(6) doi: 10.1111/liv.70700
|
| 47 |
T. E. Polunina. Risk stratification in alcoholic cirrhosis of the liver: a case study. Meditsinskiy sovet = Medical Council 2023; (8) doi: 10.21518/ms2023-129
|
| 48 |
Eric Felli, Jordi Gracia-Sancho. Regenerative Hepatology and Liver Transplantation. 2025; doi: 10.1016/B978-0-12-823524-9.00022-8
|
| 49 |
Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Aliya Alieva, Ekaterina Kashuh, Ekaterina Tsvetaeva, Elena Poluektova, Elena Shirokova, Konstantin Ivashkin. Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis. World Journal of Hepatology 2021; 13(5): 557-570 doi: 10.4254/wjh.v13.i5.557
|
| 50 |
Yunqi Xing, Yanghao Ou, Yujie Wang, Luming Hou, Junfeng Zhu. New insights into gut-liver axis in advanced liver diseases: A promising therapeutic target. Biochemical Pharmacology 2025; 242 doi: 10.1016/j.bcp.2025.117284
|
| 51 |
Lukas Hartl, Benedikt Simbrunner, Mathias Jachs, Peter Wolf, David Josef Maria Bauer, Bernhard Scheiner, Lorenz Balcar, Georg Semmler, Michael Schwarz, Rodrig Marculescu, Varius Dannenberg, Michael Trauner, Mattias Mandorfer, Thomas Reiberger. Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortality. JHEP Reports 2024; 6(1) doi: 10.1016/j.jhepr.2023.100954
|
| 52 |
Benedikt Simbrunner, Esther Caparrós, Teresa Neuwirth, Philipp Schwabl, Philipp Königshofer, David Bauer, Rodrig Marculescu, Michael Trauner, Bernhard Scheiner, Georg Stary, Mattias Mandorfer, Thomas Reiberger, Rubén Francés. Bacterial translocation occurs early in cirrhosis and triggers a selective inflammatory response. Hepatology International 2023; 17(4) doi: 10.1007/s12072-023-10496-y
|
| 53 |
Thit Mynster Kronborg, Henriette Ytting, Lise Hobolth, Søren Møller, Nina Kimer. Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based Study. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.718896
|
| 54 |
Zhi Wang, Nuo Li, Chen Zhao, Chenjing Hui, Sen Zhao, Qi Zheng, Hanwen Cheng, Yongcheng Ding, Bei Miao. Intestinal mucosal barrier injury: insights from interdisciplinary perspectives and therapeutic approaches. Frontiers in Nutrition 2026; 13 doi: 10.3389/fnut.2026.1703567
|
| 55 |
Sean M Morris, Nadir Abbas, Daniel-Clement Osei-Bordom, Simon P Bach, Dhiraj Tripathi, Neil Rajoriya. Cirrhosis and non-hepatic surgery in 2023 – a precision medicine approach. Expert Review of Gastroenterology & Hepatology 2023; 17(2) doi: 10.1080/17474124.2023.2163627
|
| 56 |
Dacheng Xiong, Huixian Geng, Xuechun Lv, Shuqi Wang, Lijing Jia. Inflammatory Response and Anti-Inflammatory Treatment in Persistent Inflammation-Immunosuppression-Catabolism Syndrome (PICS). Journal of Inflammation Research 2025; doi: 10.2147/JIR.S504694
|
| 57 |
Mingchun Huang, Ya Wang, Yanyan Li, Weiwei Zeng. Hyperoside ameliorates NAFLD in rats via remodeling gut microbiota and reprogramming serum metabolic networks. Frontiers in Nutrition 2026; 12 doi: 10.3389/fnut.2025.1741026
|
| 58 |
Andrea Kornfehl, Anja Tiede, Paul Hemetsberger, Julia Kappel, Theresa Müllner-Bucsics, Lena Stockhoff, Hannah Rieland, Lukas Reider, Nina Dominik, Georg Kramer, Michael Trauner, Mattias Mandorfer, Christine Falk, Benjamin Maasoumy, Thomas Reiberger, Lukas Hartl. Decreasing interleukin-6 levels after TIPS predict outcomes in decompensated cirrhosis. JHEP Reports 2025; 7(4) doi: 10.1016/j.jhepr.2024.101308
|
| 59 |
Jiwon Yang, Jihye Lim, Eun Hye Kim, Jihyun An, Danbi Lee, Han Chu Lee, Jin-Yong Jeong, Ju Hyun Shim. Prognostic Role of Short-Chain Fatty Acid-Producing Gut Microbiota and Gut Microbial Dynamics in Patients with Hepatocellular Carcinoma Receiving Chemoembolization: A Prospective Study. Journal of Hepatocellular Carcinoma 2025; doi: 10.2147/JHC.S537216
|
| 60 |
Lukas Hartl, Mathias Jachs, Benedikt Simbrunner, David J. M. Bauer, Georg Semmler, Daniela Gompelmann, Thomas Szekeres, Peter Quehenberger, Michael Trauner, Mattias Mandorfer, Bernhard Scheiner, Thomas Reiberger. Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19. Journal of Personalized Medicine 2021; 11(12) doi: 10.3390/jpm11121264
|
| 61 |
Thomas Heller, Daniel P. R. Herlemann, Anabel Plieth, Jens‐Christian Kröger, Marc‐André Weber, Johannes Reiner, Robert Jaster, Bernd Kreikemeyer, Georg Lamprecht, Holger Schäffler. Liver cirrhosis and antibiotic therapy but not TIPS application leads to a shift of the intestinal bacterial communities: A controlled, prospective study. Journal of Digestive Diseases 2024; 25(3) doi: 10.1111/1751-2980.13262
|
| 62 |
Benedikt Simbrunner, Rafael Paternostro, Thomas Reiberger, Michael Trauner. Bile acid signaling in MASLD: From pathogenesis to therapeutic applications. Hepatology 2025; doi: 10.1097/HEP.0000000000001539
|
| 63 |
Xiaoliang He, Yingya Zhou, Jingtao Yu, Qinpo Huang, Zhengyuan Chen, Ru Xiao, Changhui Liu, Shuhua Gui, Tianqin Xiong. JiaGaSongTang improves chronic cholestasis via enhancing FXR-mediated bile acid metabolism. Phytomedicine 2024; 128 doi: 10.1016/j.phymed.2024.155347
|
| 64 |
G Henin, N Lanthier, G Dahlqvist. Pathophysiological changes of the liver-muscle axis in end-stage liver disease: what is the right target?. Acta Gastro Enterologica Belgica 2022; 85(4) doi: 10.51821/85.4.10899
|
| 65 |
Ayman H. Gaballah, Maged Algazzar, Irfan A. Kazi, Mohamed Badawy, Nicholas Philip Guys, Eslam Adel Shehata Mohamed, Jennifer Sammon, Khaled M. Elsayes, Peter S. Liu, Matthew Heller. The Peritoneum: Anatomy, Pathologic Findings, and Patterns of Disease Spread. RadioGraphics 2024; 44(8) doi: 10.1148/rg.230216
|
| 66 |
Pierre Raeven, Joanna Baron-Stefaniak, Benedikt Simbrunner, Alexander Stadlmann, Philipp Schwabl, Bernhard Scheiner, Eva Schaden, Ernst Eigenbauer, Peter Quehenberger, Mattias Mandorfer, David Marek Baron, Thomas Reiberger. Thromboelastometry in patients with advanced chronic liver disease stratified by severity of portal hypertension. Hepatology International 2020; 14(6) doi: 10.1007/s12072-020-10093-3
|
| 67 |
Mattias Mandorfer, Virginia Hernández-Gea, Juan Carlos García-Pagán, Thomas Reiberger. Noninvasive Diagnostics for Portal Hypertension: A Comprehensive Review. Seminars in Liver Disease 2020; 40(03) doi: 10.1055/s-0040-1708806
|
| 68 |
Katharina Pomej, Lorenz Balcar, Bernhard Scheiner, Georg Semmler, Tobias Meischl, Mattias Mandorfer, Thomas Reiberger, Christian Müller, Michael Trauner, Matthias Pinter. Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib. Journal of Hepatocellular Carcinoma 2021; doi: 10.2147/JHC.S317957
|
| 69 |
Benedikt Silvester Hofer, Benedikt Simbrunner, Lukas Hartl, Mathias Jachs, David Josef Maria Bauer, Lorenz Balcar, Rafael Paternostro, Philipp Schwabl, Georg Semmler, Bernhard Scheiner, Albert Friedrich Staettermayer, Michael Trauner, Mattias Mandorfer, Thomas Reiberger. Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis. Clinical Gastroenterology and Hepatology 2023; 21(9) doi: 10.1016/j.cgh.2022.11.033
|
| 70 |
Jing Chen, Lu Zhang, Yuyan Chen, Yang Yan, Cuihua Lu. Alpha-tocopheryl quinone attenuates liver fibrosis through enriching Christensenella minuta and modulating bile acids metabolism via gut-liver axis. Phytomedicine 2025; 146 doi: 10.1016/j.phymed.2025.157108
|
| 71 |
Alexander Queck, Frank E. Uschner, Philip G. Ferstl, Martin Schulz, Maximilian J. Brol, Michael Praktiknjo, Robert Schierwagen, Sabine Klein, Christian P. Strassburg, Carsten Meyer, Christian Jansen, Marie-Luise Berres, Jonel Trebicka, Pavel Strnad. Role of circulating angiogenin levels in portal hypertension and TIPS. PLOS ONE 2021; 16(8) doi: 10.1371/journal.pone.0256473
|
| 72 |
Roman Maslennikov, Vladimir Ivashkin, Aliya Alieva, Elena Poluektova, Anna Kudryavtseva, George Krasnov, Maria Zharkova, Yuri Zharikov. Gut dysbiosis and body composition in cirrhosis. World Journal of Hepatology 2022; 14(6): 1210-1225 doi: 10.4254/wjh.v14.i6.1210
|
| 73 |
Sevag Hamamah, Oana C. Iatcu, Mihai Covasa. Dietary Influences on Gut Microbiota and Their Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Nutrients 2024; 17(1) doi: 10.3390/nu17010143
|
| 74 |
Fujimasa Tada, Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Atsushi Naganuma, Hisashi Kosaka, Tomomitsu Matono, Hidekatsu Kuroda, Yutaka Yata, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Keisuke Yokohama, Hiroki Nishikawa, Michitaka Imai, Yohei Koizumi, Shinichiro Nakamura, Hiroko Iijima, Masaki Kaibori, Yoichi Hiasa, Takashi Kumada. Efficacy and safety of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma patients with esophageal–gastric varices. Journal of Gastroenterology 2023; 58(11) doi: 10.1007/s00535-023-02026-2
|
| 75 |
Rémy Schwarzer, Thomas Reiberger, Mattias Mandorfer, Danijel Kivaranovic, Silvia Hametner, Stephanie Hametner, Rafael Paternostro, Bernhard Scheiner, Jenifer Schneeweiss-Friedl, Michael Trauner, Rainer Schoefl, Andreas Maieron. The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis. Journal of Gastroenterology 2020; 55(5) doi: 10.1007/s00535-019-01656-9
|
| 76 |
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Viral Liver Disease and Intestinal Gut–Liver Axis. Gastrointestinal Disorders 2024; 6(1) doi: 10.3390/gidisord6010005
|
| 77 |
Roman Maslennikov, Irina Efremova, Vladimir Ivashkin, Maria Zharkova, Elena Poluektova, Elena Shirokova, Konstantin Ivashkin. Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trial. World Journal of Hepatology 2022; 14(8): 1667-1677 doi: 10.4254/wjh.v14.i8.1667
|
| 78 |
Evance Pakuwal, Jin Lin Tan, Richard J. Woodman, Amanda J. Page, Andrea M. Stringer, Mohamed Asif Chinnaratha. A systematic review and meta-analysis on the efficacy of fecal microbiome transplantation in patients with severe alcohol-associated hepatitis. European Journal of Gastroenterology & Hepatology 2025; 37(11) doi: 10.1097/MEG.0000000000003003
|
| 79 |
Mattias Mandorfer, Benedikt Simbrunner. Prevention of First Decompensation in Advanced Chronic Liver Disease. Clinics in Liver Disease 2021; 25(2) doi: 10.1016/j.cld.2021.01.003
|
| 80 |
Julian Pohl, Dimitrios Aretakis, Frank Tacke, Cornelius Engelmann, Michael Sigal. Role of Intestinal Barrier Disruption to Acute-on-Chronic Liver Failure. Seminars in Liver Disease 2025; 45(01) doi: 10.1055/a-2516-2361
|
| 81 |
Zefeng Chen, Jingsheng Ruan, Dinghua Li, Min Wang, Zhiwei Han, Wenxia Qiu, Guobin Wu. The Role of Intestinal Bacteria and Gut–Brain Axis in Hepatic Encephalopathy. Frontiers in Cellular and Infection Microbiology 2021; 10 doi: 10.3389/fcimb.2020.595759
|
| 82 |
Huimin Kang, Yongjia Feng, Baodong Wang, Zheng Chen, Jingya Li, Zhiyun Chen. From gasotransmitter to therapeutic insight: Unraveling the role of H₂S in the gut-liver axis during NAFLD. Pharmacological Research 2026; 225 doi: 10.1016/j.phrs.2026.108108
|
| 83 |
Ji Yoon Kwak, Hankyu Jeon, Hyeon Uk Kwon, Jae Eun Kim, Ji Hee Han, Jung Woo Choi, Ra Ri Cha, Jae Min Lee, Sang Soo Lee. Recompensation following first decompensation in patients with alcohol-related cirrhosis. BMC Gastroenterology 2026; 26(1) doi: 10.1186/s12876-026-04651-6
|
| 84 |
Benedikt Simbrunner, Ida Falk Villesen, Philipp Königshofer, Bernhard Scheiner, David Bauer, Rafael Paternostro, Philipp Schwabl, Gerald Timelthaler, Dariga Ramazanova, Katharina Wöran, Judith Stift, Ernst Eigenbauer, Albert Friedrich Stättermayer, Rodrig Marculescu, Matthias Pinter, Søren Møller, Michael Trauner, Morten Karsdal, Diana Julie Leeming, Thomas Reiberger, Mattias Mandorfer. Systemic inflammation is linked to liver fibrogenesis in patients with advanced chronic liver disease. Liver International 2022; 42(11) doi: 10.1111/liv.15365
|
| 85 |
Noemi Daradics, Pim B. Olthof, Andras Budai, Michal Heger, Thomas M. van Gulik, Andras Fulop, Attila Szijarto. The Role of Farnesoid X Receptor in Accelerated Liver Regeneration in Rats Subjected to ALPPS. Current Oncology 2021; 28(6) doi: 10.3390/curroncol28060438
|
| 86 |
Benedikt Simbrunner, Michael Trauner, Thomas Reiberger. Review article: therapeutic aspects of bile acid signalling in the gut‐liver axis. Alimentary Pharmacology & Therapeutics 2021; 54(10) doi: 10.1111/apt.16602
|
| 87 |
Chunxia Yu, Sujuan Liu, Yanmei Niu, Li Fu. Exercise protects intestinal epithelial barrier from high fat diet- induced permeabilization through SESN2/AMPKα1/HIF-1α signaling. The Journal of Nutritional Biochemistry 2022; 107 doi: 10.1016/j.jnutbio.2022.109059
|
| 88 |
Tingshuai Wang, Shaodong Huang, Cong Wu, Na Wang, Rongzhen Zhang, Minggang Wang, Dewen Mao, Célia Cabral. Intestinal Microbiota and Liver Diseases: Insights into Therapeutic Use of Traditional Chinese Medicine. Evidence-Based Complementary and Alternative Medicine 2021; 2021 doi: 10.1155/2021/6682581
|
| 89 |
Qing Liu, Siyi Zhu, Xinmu Li, Wentao Li, Xiang Li, Yunxing Xu, Qiuhui Yu, Weixi Hua, Hua Yang, Zheng Wang. Integrated Multi‐Omics Elucidates the Protective Mechanism of Polygonatum odoratum Extract Against Cyclophosphamide‐Induced Hepatointestinal Injury via the Liver–Gut Axis and JAK/STAT3 Pathway. Food Frontiers 2026; 7(2) doi: 10.1002/fft2.70267
|
| 90 |
Kurt Grüngreiff, Dirk Reinhold, Wolfgang Maret. Roles of zinc in the gut-liver axis. Annals of Hepatology 2026; doi: 10.1016/j.aohep.2026.102188
|
| 91 |
Yan-Jiao Wang, Ya-Bi Zhu, Wen-Jia Wei. Effect of non-selective β-receptor blockers on inflammatory factors and prognosis in advanced chronic liver disease. World Chinese Journal of Digestology 2021; 29(19) doi: 10.11569/wcjd.v29.i19.1110
Abstract(921) |
Core Tip(880) |
Full Article(HTML)(2717)
|
Times Cited (0)
|
Total Visits (3900)
|
Open
|
| 92 |
Irina Efremova, Roman Maslennikov, Elena Poluektova, Maria Zharkova, Anna Kudryavtseva, George Krasnov, Maria Fedorova, Elena Shirokova, Evgenii Kozlov, Anna Levshina, Vladimir Ivashkin. Gut Dysbiosis and Hemodynamic Changes as Links of the Pathogenesis of Complications of Cirrhosis. Microorganisms 2023; 11(9) doi: 10.3390/microorganisms11092202
|
| 93 |
Yuanchao Zheng, Ziwei Gao, Lei Sun, Jieyi Shi, Jingru Song, Wei Ye. Calcium and Gastrointestinal Disorders: Mechanistic Insights and Therapeutic Interventions. International Journal for Vitamin and Nutrition Research 2025; 95(5) doi: 10.31083/IJVNR39241
|
| 94 |
Irina Efremova, Roman Maslennikov, Elena Poluektova, Oleg Medvedev, Anna Kudryavtseva, George Krasnov, Maria Fedorova, Filipp Romanikhin, Vyacheslav Bakhitov, Salekh Aliev, Natalia Sedova, Tatiana Kuropatkina, Anastasia Ivanova, Maria Zharkova, Ekaterina Pervushova, Vladimir Ivashkin. Gut Microbiota and Biomarkers of Endothelial Dysfunction in Cirrhosis. International Journal of Molecular Sciences 2024; 25(4) doi: 10.3390/ijms25041988
|
| 95 |
Ying-Zi Qi, Yue-Hua Jiang, Ling-Yu Jiang, Lin-Lin Shao, Xue-Song Yang, Chuan-Hua Yang. An Insight Into Intestinal Microbiota of Spontaneously Hypertensive Rats After Valsartan Administration. Dose-Response 2021; 19(2) doi: 10.1177/15593258211011342
|
| 96 |
Benedikt Simbrunner, Benedikt S. Hofer, Philipp Schwabl, Kerstin Zinober, Oleksandr Petrenko, Claudia Fuchs, Georg Semmler, Rodrig Marculescu, Mattias Mandorfer, Christian Datz, Michael Trauner, Thomas Reiberger. FXR-FGF19 signaling in the gut–liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defence. Hepatology International 2024; 18(3) doi: 10.1007/s12072-023-10636-4
|
| 97 |
Po-Yu Huang, Hsuan-Miao Liu, Yan-Ru Ko, Zi-Yu Chang, Tzung-Yan Lee. Electroacupuncture relieves portal hypertension by improving vascular angiogenesis and linking gut microbiota in bile duct ligation rats. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1207137
|
| 98 |
Brett McGettigan, Maria Hernandez-Tejero, Harmeet Malhi, Vijay Shah. Immune Dysfunction and Infection Risk in Advanced Liver Disease. Gastroenterology 2025; 168(6) doi: 10.1053/j.gastro.2024.08.046
|
| 99 |
Benedikt Silvester Hofer, Benedikt Simbrunner, Philipp Königshofer, Ksenia Brusilovskaya, Oleksandr Petrenko, Vlad Taru, Thomas Sorz, Kerstin Zinober, Georg Semmler, Stefan G. Kauschke, Larissa Pfisterer, Michael Trauner, Mattias Mandorfer, Philipp Schwabl, Thomas Reiberger. Aetiology-specific inflammation patterns in patients and rat models of compensated cirrhosis. Digestive and Liver Disease 2025; 57(2) doi: 10.1016/j.dld.2024.09.006
|
| 100 |
霞 万. Research Progress of Intestinal Complications in End-Stage Liver Disease. Advances in Clinical Medicine 2024; 14(01) doi: 10.12677/ACM.2024.141061
|
| 101 |
Benedikt Silvester Hofer, Benedikt Simbrunner, Philipp Königshofer, Ksenia Brusilovskaya, Oleksandr Petrenko, Vlad Taru, Thomas Sorz‐Nechay, Kerstin Zinober, Katharina Regnat, Georg Semmler, Carolin Lackner, Michael Trauner, Mattias Mandorfer, Philipp Schwabl, Thomas Reiberger. Inflammation remains a dynamic component of portal hypertension in regressive alcohol‐related cirrhosis. United European Gastroenterology Journal 2025; 13(3) doi: 10.1002/ueg2.12643
|
| 102 |
Catalina Olaru-Stavila, Sara Martina Steinmann, Patricia Mester, Martina Müller, Eugen Tcaciuc, Karsten Gülow. The Gastrointestinal Barrier—Mechanisms of Barrier Dysfunction in Liver Cirrhosis and Spontaneous Bacterial Peritonitis. Biomedicines 2026; 14(5) doi: 10.3390/biomedicines14051084
|